Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Shula Recanati
AddedFeb 20, 2024
UpdatedMay 1, 2026
Shula Recanati

Shula Recanati

Board Member, Rainbow Medical

Shula Recanati's Career

Rainbow Medical
Rainbow Medical

Herzliya, Tel Aviv District, IL

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Shula Recanati's Career

Rainbow Medical
Rainbow Medical
Series B$25M1252011Herzliya, Tel Aviv District, IL
Board Member· Board

Leadership at Rainbow Medical

Leon RecanatiLeon RecanatiBoard Member
Ilan NeugartenIlan NeugartenBoard Member
Yossi GrossYossi GrossBoard Member
William CastellWilliam CastellBoard Member
Efi Cohen AraziEfi Cohen AraziBoard Member
Boris KalandarBoris KalandarBoard Member

Similar to Rainbow Medical

Renata MedicalRenata MedicalCosta Mesa, CA, USMedical Devicesest. 2019Renata MedicalCosta Mesa, CA, US · est. 2019

Renata Medical: Innovating safe, versatile medical devices for unmet congenital heart needs.

Series B · $15.9M8
ExploraMed NC7ExploraMed NC7Mountain View, CA, USMedical Devicesest. 2014ExploraMed NC7Mountain View, CA, US · est. 2014

ExploraMed, a US-based medical tech incubator, accelerates the creation of innovative medical devices, meeting global health needs.

Series C · $132.6M30
Proa MedicalProa MedicalRedondo Beach, CA, USMedical Devicesest. 2010Proa MedicalRedondo Beach, CA, US · est. 2010

Proa Medical: High-throughput developer and distributor of innovative medical devices.

Pre-Seed · $2.8M2
Fairway Medical TechnologiesFairway Medical TechnologiesHouston, TX, USMedical Devicesest. 1992Fairway Medical TechnologiesHouston, TX, US · est. 1992

Fairway: Innovating and manufacturing cutting-edge medical device technologies.

Seed · $185k11

Shula Recanati's Similar Executives & Operators

Jay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · KakaoYun SeokYun SeokBoard Member · Kakao

People Similar to Shula Recanati

Barak PridorBarak PridorBoard Member · ApplicasterNeal B ShapiroNeal B ShapiroBoard Member · TegnaDavid SaltzmanDavid SaltzmanBoard Member · Mode MediaemadeddinemadeddinBoard Member · CargillKoleman KarleskiKoleman KarleskiBoard Member · AfterbotEric ReiterEric ReiterBoard Member · KeyMe